Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...

NPR's weekly news quiz hosted by Peter Sagal. Have a laugh and test your knowledge with today's funniest comedians and a celebrity guest.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Near 52 Week High Stocks: Check the list of near 52 week high stocks during the day on NSE/BSE. Find and analyse the stocks / shares which have touched near 52 week high on NSE/BSE. Multiply the power ...